Skip to Content

Separator 3D Trial

Objective

A randomized, concurrent controlled trial to assess the safety and effectiveness of the Separator 3D as a component of the Penumbra System in the revascularization of the large vessel occlusion in acute ischemic stroke.

 

For more information about Dr. Chowdhary, please click here.

Principal Investigator(s)
Abhineet Chowdhary, MD

Clinical Trial Categories

  • Neurosurgery
Sponsor(s)
Overlake Research
Contact
Research Study Staff at 425-467-3986

Location

  • Overlake Hospital Medical Center
    1035 116th Ave. NE
    Bellevue, WA 98004
    Main: 425-688-5000